OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

3 Projects | 1 Researchers | $478,100 Invested

2003

Tel Aviv University

Illana Gozes, PhD

Summer Neuropeptide 2003 Conference

  • Funding Amount: $5,000
  • Organization Type: Academic/Nonprofit
  • Program: Conferences/Other
  • Status: Closed

2002

Allon Therapeutics, Inc.

Illana Gozes, PhD

Alzheimer's Disease Biotech Program

  • Funding Amount: $253,100
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Status: Closed

1999

Tel Aviv University

Illana Gozes, PhD

Femtomolar-Acting Neuroprotective Peptides: Application for Inhibition of Neurodegenerative Disease

  • Funding Amount: $220,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed